261 related articles for article (PubMed ID: 6304695)
1. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
[TBL] [Abstract][Full Text] [Related]
2. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
[TBL] [Abstract][Full Text] [Related]
3. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
Roques BP; Fournié-Zaluski MC; Soroca E; Lecomte JM; Malfroy B; Llorens C; Schwartz JC
Nature; 1980 Nov; 288(5788):286-8. PubMed ID: 7001254
[TBL] [Abstract][Full Text] [Related]
4. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
[TBL] [Abstract][Full Text] [Related]
5. 1H NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of "enkephalinase" inhibitors. Relationships between stereochemistry and enzyme recognition.
Fournié-Zaluski MC; Lucas-Soroca E; Devin J; Roques BP
J Med Chem; 1986 May; 29(5):751-7. PubMed ID: 3517331
[TBL] [Abstract][Full Text] [Related]
6. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
[TBL] [Abstract][Full Text] [Related]
7. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
[TBL] [Abstract][Full Text] [Related]
8. Differential recognition of "enkephalinase" and angiotensin-converting enzyme by new carboxyalkyl inhibitors.
Fournié-Zaluski MC; Soroca-Lucas E; Waksman G; Llorens C; Schwartz JC; Roques BP
Life Sci; 1982 Dec; 31(26):2947-54. PubMed ID: 6298535
[TBL] [Abstract][Full Text] [Related]
9. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
[TBL] [Abstract][Full Text] [Related]
10. Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitors.
Fournie-Zaluski MC; Lucas E; Waksman G; Roques BP
Eur J Biochem; 1984 Mar; 139(2):267-74. PubMed ID: 6321177
[TBL] [Abstract][Full Text] [Related]
11. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
Bouboutou R; Waksman G; Devin J; Fournié-Zaluski MC; Roques BP
Life Sci; 1984 Aug; 35(9):1023-30. PubMed ID: 6088932
[TBL] [Abstract][Full Text] [Related]
12. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity.
Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S
J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797
[TBL] [Abstract][Full Text] [Related]
13. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
[TBL] [Abstract][Full Text] [Related]
14. Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin.
Llorens-Cortes C; Schwartz JC
Eur J Pharmacol; 1984 Sep; 104(3-4):369-74. PubMed ID: 6594244
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of enkephalin-degradating enzymes from calf-brain striatum.
van Amsterdam JG; van Buuren KJ; Soudijn W
Biochem Biophys Res Commun; 1983 Sep; 115(2):632-41. PubMed ID: 6578795
[TBL] [Abstract][Full Text] [Related]
16. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.
Fournié-Zaluski MC; Coulaud A; Bouboutou R; Chaillet P; Devin J; Waksman G; Costentin J; Roques BP
J Med Chem; 1985 Sep; 28(9):1158-69. PubMed ID: 3897541
[TBL] [Abstract][Full Text] [Related]
17. The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum.
Aoki K; Kajiwara M; Oka T
Jpn J Pharmacol; 1984 Sep; 36(1):59-65. PubMed ID: 6094902
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the inhibitory potencies of thiorphan and retrothiorphan enantiomers on thermolysin and neutral endopeptidase 24.11 and their interactions with the thermolysin active site by computer modelling.
Benchetrit T; Fournié-Zaluski MC; Roques BP
Biochem Biophys Res Commun; 1987 Sep; 147(3):1034-40. PubMed ID: 3478046
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
[TBL] [Abstract][Full Text] [Related]
20. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]